After a sharp drop in out-of-pocket costs between 2010 and 2011, Medicare patients who use specialty biologic medications for rheumatoid arthritis have seen higher out-of-pocket spending for those same drugs because of gradual price increases, a new study in the Journal of the American Medical Association Open finds.
- New perspectives challenge the idea that saturated fats cause heart disease
- University of Cincinnati student uses zebrafish to study spinal deformities
- Reducing traps increases performance of organic photodetectors
- Novel target identified that could improve safety of therapy for pancreatic cancer
- Addressing the impact of structural racism on disparities in children with Type 1 diabetes